We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Latest updates on SARS-CoV-2 variants detected in the UK.
Tuberculosis (TB) cases in England increased by 7% in the first half of 2023 compared to the same timeframe in 2022.
Precautionary measure taken to protect those most vulnerable from illness during winter following the identification of COVID-19 variant BA.2.86.
First published during the 2022 to 2024 Sunak Conservative government
The £1 million presymptomatic mpox (monkeypox) PRIME study hopes to recruit 2,000 participants in England.
UKHSA data reveals 70,649 people living with hepatitis C in England in 2022, marking a 45% decrease since 2015.
Latest update from the UK Health Security Agency (UKHSA) on the risk to human health from avian influenza (influenza A H5N1).
Introduction of Shingrix® vaccine for the whole programme and expansion of eligible cohorts.
All secondary school pupils eligible for free flu vaccine as government expands vaccination programme.
Moving from 2 to 1 dose schedule for those aged under 25 years in the universal and MSM HPV programmes.
UKHSA is reminding Hajj and Umrah pilgrims to prioritise Middle East Respiratory Syndrome (MERS-CoV) safety measures when travelling to the Middle East.
Last year, gonorrhoea diagnoses were highest on record and syphilis diagnoses were highest since 1948.
The UK Health Security Agency (UKHSA) urges people to remain vigilant as a further 10 cases of mpox (monkeypox) have been diagnosed in the UK.
UK government announces up to £39 million cash injection for antimicrobial resistance (AMR) research through the Global AMR Innovation Fund (GAMRIF).
UKHSA has detected influenza A (H5) virus in 2 poultry workers, following the introduction of an asymptomatic testing programme for people who have been in contact with infected birds.
Latest data from the UK Health Security Agency (UKHSA) on scarlet fever and invasive group A streptococcus cases.
The offer of a first or second dose of COVID-19 vaccine will end on 30 June 2023 for most people.
A new study aims to better understand how the body reacts to the mpox virus and produces antibodies.
A new risk assessment, published by a multi-agency cross-government committee, reports that tick borne encephalitis is now likely to be present in England.
Fewer poliovirus detections in London show signs of reduced community transmission but vaccine rates in some London boroughs still too low.
Sustained reduction in case numbers means targeted vaccine programme is no longer needed and can be wound down in the summer.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).